Boston Scientific (BSX) Revenue (2009 - 2026)

Boston Scientific has disclosed Revenue across 18 years of filings, most recently posting $5.4 billion for Q2 2026.

• In Q2 2026, Revenue rose 7.53% year-over-year to $5.4 billion; the TTM figure through Jun 2026 stood at $21.0 billion (up 13.53% YoY), while the FY2025 annual figure was $20.1 billion, up 19.87% from the prior year.
• Revenue came in at $5.4 billion for Q2 2026 at Boston Scientific, up from $5.2 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $5.4 billion in Q2 2026 to a low of $3.0 billion in Q1 2022.
• Average Revenue over 5 years is $4.1 billion, with a median of $4.0 billion recorded in 2024.
• Year-over-year, Revenue increased 3.68% in 2022 and increased 22.84% in 2025.
• Over 5 years, Revenue stood at $3.2 billion in 2022, then climbed by 14.9% to $3.7 billion in 2023, then grew by 22.44% to $4.6 billion in 2024, then advanced by 15.9% to $5.3 billion in 2025, then grew by 2.95% to $5.4 billion in 2026.
• Per Business Quant data, the three most recent Revenue figures were $5.4 billion in Q2 2026, $5.2 billion in Q1 2026, and $5.3 billion in Q4 2025.